e.l.f. Beauty (ELF) investor relations material

Executive summary

• Achieved 36% year-over-year net sales growth in Q1 FY2027, marking the 30th consecutive quarter of net sales growth, with all brands expected to grow for the remainder of the year.

• Raised FY2027 net sales growth outlook to 18–20% from previous 12–14% guidance, reflecting strong momentum across the portfolio.

• Rhode contributed approximately $160 million in Q1 net sales, with a record-breaking $27 million DTC sales day and major international expansion plans.

• Completed $897.5 million acquisition of rhode, expanding the skin care portfolio.

• Continued diversification with non-e.l.f. sales now over 30%, skincare at nearly 25%, and digital penetration at 30%.

Financial highlights

• Net sales reached $479.4 million in Q1 FY2027, up 36% year-over-year; U.S. net sales up 29%, international up 61%.

• Gross margin reached 83%, up 1,400 basis points, including a $50 million IEEPA tariff refund; excluding this, gross margin up 350 basis points.

• Adjusted EBITDA was $168 million, up 93% year-over-year; excluding tariff refunds, up 36%.

• Adjusted net income was $105 million ($1.75/share), up from $51 million ($0.89/share) last year.

• Ended Q1 with $344 million in cash, up from $170 million a year ago.

Outlook and guidance

• FY2027 net sales expected between $1,938–$1,968 million, up from prior $1,835–$1,865 million; net sales growth outlook raised to 18–20%.

• Adjusted EBITDA guidance raised to $401–$407 million; adjusted EPS guidance increased to $3.50–$3.55.

• Rhode expected to contribute 13 percentage points to net sales growth; organic growth outlook raised to 6–7%.

• Gross margin for FY2027 expected to be up 200 basis points year-over-year, with marketing and digital spend at the high end of 23–25% of net sales.

• Full reinvestment of $50 million tariff refund into pricing actions and marketing.